Johnson & Johnson halts late-stage E.coli vaccine trial after poor results
Johnson & Johnson and Sanofi said that while the vaccine showed no safety concerns, it did not meet the necessary ...
Johnson & Johnson announces Phase 3 ASTRO study met primary endpoints
Johnson & Johnson announced data from the Phase 3 ASTRO study of TREMFYA subcutaneous, SC, induction therapy in adults with moderately to ...
Wall Street Journal4d
Johnson & Johnson Goes to Trial on Third Talc Bankruptcy Plan
Healthcare conglomerate Johnson & Johnson on Tuesday kicked off a bankruptcy-court trial on its third attempt to resolve one of the largest-ever mass tort lawsuits through a chapter 11 case.
Bloomberg L.P.5d
What J&J Is Trying to Achieve in Bankruptcy Court
Johnson & Johnson begins a two-week trial on Feb. 18 over its plan to end tens of thousands of lawsuits filed by women or their family members who claim its baby powder gave them cancer.
pharmaphorum4d
Name change for Johnson & Johnson offshoot to Kenvue
Johnson & Johnson’s Consumer Health segment reported a revenue of $14.6 billion in the Full-Year 2021. It is projected that, following the separation, Kenvue will generate sales in over 100 ...
Can AI Unlock New Treatment Possibilities For Inflammatory Bowel Disease? How Johnson & Johnson Is Leading The Way
Johnson & Johnson, a leader in immunology, has developed ARGES, a new AI-powered tool that could transform endoscopic ...
The Straits Times9d
J&J, Sanofi stop E.coli vaccine trial due to low effectiveness
Johnson & Johnson and partner Sanofi will stop a late-stage trial of an experimental vaccine to prevent infections caused by the E.coli bacteria due to a lack of sufficient efficacy ...
Metro28d
‘I got cancer after using Johnson & Johnson talcum powder – now I’m suing them’
Julie Whytock, 64, from Hertfordshire, says she developed ovarian cancer after using Johnson & Johnson (J&J) talc powder ‘at least once a day’ as a young child. After her diagnosis with stage ...